Perbak Capital Partners’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,896
Closed -$1.04M 56
2026
Q1
$1.04M Buy
+3,896
New +$1.08M 0.26% 40
2025
Q4
Sell
-1,432
Closed -$413K 240
2025
Q3
$413K Sell
1,432
-3,329
-70% -$985K 0.07% 248
2025
Q2
$1.57M Buy
+4,761
New +$1.53M 0.36% 38
2025
Q1
Sell
-2,051
Closed -$566K 195
2024
Q4
$566K Sell
2,051
-8,289
-80% -$2.64M 0.3% 53
2024
Q3
$3.58M Buy
10,340
+4,931
+91% +$1.7M 2.51% 8
2024
Q2
$1.79M Buy
+5,409
New +$1.87M 0.53% 42

Other funds holding CI

Perbak Capital Partners's CI Position: Q2 2026 in Review

Perbak Capital Partners sold out of Cigna (CI) in Q2 2026, closing a stake of 3,896 shares — an estimated $1.04M sold.

Perbak Capital Partners first reported a position in CI in Q2 2024 and held it in 6 quarters. The position peaked at $3.58M in Q3 2024. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Perbak Capital Partners reported no remaining Cigna position as of Q2 2026 after selling out during the quarter.
  • Perbak Capital Partners sold 3,896 Cigna shares in Q2 2026, an estimated $1.04M.
  • Perbak Capital Partners first reported a position in Cigna in Q2 2024 and held it in 6 quarters.
  • Perbak Capital Partners's Cigna position peaked at $3.58M in Q3 2024.
  • 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.